MOGwAI : A Randomized Double Blind, Placebo-Controlled Multicenter Phase 3 Trial to Evaluate the Efficacy of Azathioprine for Prevention of Relapse in Patients with Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease after a First Attack
MULTIPLE SCLEROSIS JOURNAL(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined